HELP: Helus Pharma Inc. insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
1 open-market buys totaling $39K and 0 sales totaling - in the last 180 days.
Insider buys
| Score | Ticker | Company | Insider | Role | Trade date | Value | Holding + | Cluster |
|---|---|---|---|---|---|---|---|---|
| 46 | HELP | Helus Pharma Inc. | Cavers Greg | CFO | 2026-09-29 | $39K | new |
Activist and 5% holders
| Filed | What | Holder | Stake | Change | Filing |
|---|---|---|---|---|---|
| 2026-09-09 | New 13D stake | So Eric H. L. | 5.80% | SEC | |
| 2026-09-09 | New 13D stake | Glavine Paul | 5.80% | SEC |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.